SCHEMBL25866316

SCHEMBL25866316

Cc1cc(-c2cc(C)c(F)cc2C)ccc1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.50
PTGS1 P23219 3/20 0.49
DAPK3 O43293 2/20 0.44
NTRK1 P04629 2/20 0.44
PIM1 P11309 2/20 0.44
FLT3 P36888 2/20 0.44
GSK3B P49841 2/20 0.44
ROCK1 Q13464 2/20 0.44
CLK4 Q9HAZ1 2/20 0.44
PDE3B Q13370 2/20 0.39
PDE3A Q14432 2/20 0.39
AKR1C3 P42330 1/20 0.38
AKR1C2 P52895 1/20 0.38
AURKA O14965 1/20 0.38
JAK2 O60674 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
PAK4 O96013 1/20 0.38
CSF1R P07333 1/20 0.38
RET P07949 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21022113 0.83 PTGS2 (0.46) PTGS2PTGS1PDE3BPDE3ARPS6KA3
SCHEMBL22820004 0.79 ABL1 (0.50) PTGS2PTGS1DAPK3NTRK1PIM1
SCHEMBL16574098 0.78 MAP4K4 (0.48) PTGS2PTGS1DAPK3NTRK1PIM1
SCHEMBL3641688 0.77 TNKS (0.53) PTGS2PTGS1DAPK3NTRK1PIM1
SCHEMBL14850869 0.77 ACHE (0.50) PTGS2PTGS1DAPK3NTRK1PIM1
SCHEMBL25840018 0.76 PTGS2 (0.51) PTGS2PTGS1AKR1C3AKR1C2
SCHEMBL17971121 0.75 PTGS2 (0.44) PTGS2PTGS1DAPK3NTRK1PIM1
SCHEMBL17971123 0.75 PTGS2 (0.44) PTGS2PTGS1DAPK3NTRK1PIM1
SCHEMBL13703910 0.74 AKR1C3 (0.49) PTGS2PTGS1DAPK3NTRK1PIM1
SCHEMBL394650 0.72 ALOX5AP (0.48) PTGS2PTGS1DAPK3NTRK1PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023134698-A1 PYRIDAZINE-1(6H)-6-OXO COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 深圳信立泰药业股份有限公司 2023-07-20 WO disclosed